Citations

Showing 10 of 108083 citations.

Chronic Lymphocytic Leukemia in African Ancestry Population Is Characterized By Increased Telomere Erosion
Campos, Cecília Bonolo de , McCabe, Chantal E. , Bruins, Laura A., O’Brien, Daniel R. , Brown, Sochilt , Allmer, Cristine, Zhu, Yuan Xiao , Rassenti, Laura Z., Furman, Richard R. , Weinberg, J. Brice , Brander, Danielle M. , Chesi, Marta, Rabe, Kari G. , Parikh, Sameer A. , Kay, Neil E. , Cerhan, James R. , Chesi, Marta , Slager, Susan L. , Braggio, Esteban

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4135-4136

10.1182/blood-2022-170944 Get It

Clinical Outcomes of Patients with TP53-Mutated AML after First Relapse or with Primary Refractory Disease: Results from Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Shallis, Rory M. , Stahl, Maximilian , Correia, Guillerhme Sacchi De Camargo, Palmisiano, Neil , Bradshaw, Danielle , Dinner, Shira, Litzow, Mark R. , Badar, Talha , Atallah, Ehab , Saliba, Antoine N. , Bewersdorf, Jan Philipp , Patel, Anand , Abaza, Yasmin , Murthy, Guru Subramanian Guru , DuVall, Adam , Burkart, Madelyn , Kota, Vamsi , Goldberg, Aaron D.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6058-6060

10.1182/blood-2022-163795 Get It

A Phase 1b Dose Escalation and Expansion Study of SNDX-5613, Azacitidine (AZA) and Venetoclax (VEN) in Newly Diagnosed, Patients ≥ 60 Years with Untreated NPM1-Mutated/ FLT3-Wild Type AML or KMT2A-Rearranged Acute Myeloid Leukemia (AML
Johnson, Mary Ann , Huang, Ying , Swords, Ronan , Stein, Eytan M. , Foran, James M. , Baer, Maria R. , Kovacsovics, Tibor , Olin, Rebecca L. , Blum, William , Schiller, Gary J. , Redner, Robert L. , Al‐Mansour, Zeina , Curran, Emily , Heerema, Nyla A. , Martycz, Molly , Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O. , Stefanos, Mona , Druggan, Franchesca , Burd, Amy , Borate, Uma , Byrd, John C. , Byrd, John C , Zeidner, Joshua F. , Foster, Matthew C , Johnson, Mary, Stock, Wendy , Madanat, Yazan F. , Lin, Tara L. , Chen, Timothy Frank , Levine, Ross L. , Druker, Brian J , Mims, Alice S

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9070-9073

10.1182/blood-2022-166715 Get It

Predictive Value of Staging PET/CT to Detect Bone Marrow Involvement in Marginal Zone Lymphoma (MZL): An Analysis from LEO MZL Working Group
Alderuccio, Juan Pablo , Koff, Jean L. , Zhao, Wei , Haddadi, Sara , Chapman‐Fredricks, Jennifer R., Strouse, Christopher , Cohen, Jonathon B. , Friedberg, Jonathan W. , Flowers, Christopher R. , Lossos, Izidore S. , Koff, Jean L , Strouse, Christopher S , Reis, Isildinha Marques dos , Larson, Melissa C. , Chihara, Dai , Habermann, Thomas M. , Martin, Peter, Kahl, Brad S. , Cerhan, James R.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9340-9341

10.1182/blood-2022-162688 Get It

Impact of Pegcetacoplan on Paroxysmal Nocturnal Hemoglobinuria Symptoms in Patients Previously Treated with C5-Inhibitors
Desai, Dharmik, Hadker, Nandini, Perler, Jed, O'Hara, Matthew, Hill, Laura, Dingli, David

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11443-11444

10.1182/blood-2022-163778 Get It

Health-Related Quality of Life Reported Among Patients with Paroxysmal Nocturnal Hemoglobinuria: Impact of Treatment with Pegcetacoplan and C5-Inhibitors
Desai, Dharmik, Hadker, Nandini, Francis, Amanda, Torres, Amanda Cassidy, Perler, Jed, Francis, Amanda, Hill, Laura, Dingli, David

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11445-11446

10.1182/blood-2022-163821 Get It

Does Race/Ethnicity Impact Umbilical Cord Blood Transplant Outcomes in a Contemporary Era?
Ballen, Karen K. , Wang, Tao , He, Naya, Hashmi, Shahrukh K. , Lehmann, Leslie , Rangarajan, Hemalatha G. , Saber, Wael , Wood, William A.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 685-686

10.1182/blood-2022-159152 Get It

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study
Ghesquières, Hervé , Drouet, Youenn , Robinson, Dennis P. , Novak, Anne J. , Xerri, Luc , Verney, Aurélie, Slager, Susan L. , Morschhauser, Franck , Galimberti, Sara , Thomas, Emilie , Luminari, Stefano , Laurent, Camille , Rimsza, Lisa M. , Habermann, Thomas M. , Federico, Massimo , Link, Brian K. , Salles, Gilles , Cerhan, James R.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1307-1309

10.1182/blood-2022-167466 Get It

Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis
Khurana, Arushi , Mwangi, Raphael , McDonnell, Timothy J. , Riska, Shaun M., Lossos, Izidore S. , Flowers, Christopher R. , Nowakowski, Grzegorz S. , Nastoupil, Loretta J. , Reagan, Patrick Michael , Farooq, Umar , Romancik, Jason T. , Kahl, Brad S. , Martin, Peter, Witzig, Thomas E. , Cerhan, James R. , Maurer, Matthew J.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2056-2058

10.1182/blood-2022-169433 Get It